Literature DB >> 35478103

Oral Misoprostol for the Induction of Labor: Comparison of Different Dosage Schemes With Respect to Maternal and Fetal Outcome in Patients Beyond 34 Weeks of Pregnancy.

Oana Ratiu1, Dominik Ratiu1, Peter Mallmann2, Alexander DI Liberto2, A Kubilay Ertan1, Bernd Morgenstern2, Michael R Mallmann2, Sebastian Ludwig2, Berthold Grüttner2, Christian Eichler2, Fabinshy Thangarajah2, Elena Gilman2, Judith S Abel2.   

Abstract

BACKGROUND/AIM: Labor is induced in 1 out of 5 pregnancies. This is why we aimed to compare two different protocols of orally administered misoprostol for the induction of labor (IOL), with special regard to maternal and fetal outcome, delivery mode and duration. PATIENTS AND METHODS: One hundred and twenty four patients with a medical indication for IOL were divided into two groups: Group A (n=63), which initially received 50 μg misoprostol escalated to 100 and, subsequently, to 200 μg every 4 h with a daily maximum of 600μg, between 11/2007 and 01/2008; and Group B (n=61), which initially received 25 μg misoprostol followed by 100 μg every 4 h with a daily maximum of 300 μg, between 12/2009 and 04/2010.
RESULTS: The mean administration-delivery interval was significantly lower in Group A (19.0 h) compared to Group B (27.1 h, p<0.05). Overall caesarean section rate, average birth weight, APGAR score, umbilical cord pH and meconium-stained fluid rates were similar between both groups.
CONCLUSION: A higher dosage protocol of orally administered misoprostol significantly reduces the mean induction-delivery interval without increasing the risk for an adverse maternal or fetal outcome.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Oral misoprostol; induction of labor

Mesh:

Substances:

Year:  2022        PMID: 35478103      PMCID: PMC9087102          DOI: 10.21873/invivo.12828

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.406


  18 in total

1.  Misoprostol and the debate over off-label drug use.

Authors:  Andrew D Weeks; Christian Fiala; Peter Safar
Journal:  BJOG       Date:  2005-03       Impact factor: 6.531

2.  Safety and efficacy of misoprostol orally and vaginally: a randomized trial.

Authors:  S J Carlan; S Bouldin; D Blust; W F O'Brien
Journal:  Obstet Gynecol       Date:  2001-07       Impact factor: 7.661

Review 3.  ACOG Practice Bulletin No. 107: Induction of labor.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-08       Impact factor: 7.661

4.  Maternal and fetal characteristics associated with meconium-stained amniotic fluid.

Authors:  Imelda Balchin; John C Whittaker; Ronald F Lamont; Philip J Steer
Journal:  Obstet Gynecol       Date:  2011-04       Impact factor: 7.661

5.  Amniotic fluid transitioning from clear to meconium stained during labor-prevalence and association with adverse maternal and neonatal outcomes.

Authors:  Daniel Tairy; Ohad Gluck; Ori Tal; Jacob Bar; Neri Katz; Zvia Hiaev; Michal Kovo; Eran Weiner
Journal:  J Perinatol       Date:  2019-07-18       Impact factor: 2.521

6.  A Comparison of Vaginal vs. Oral Misoprostol for Induction of Labor-Double Blind Randomized Trial.

Authors:  Promila Jindal; Kumkum Avasthi; Maninder Kaur
Journal:  J Obstet Gynaecol India       Date:  2011-10-26

7.  Induction of labour at term with oral misoprostol versus a Foley catheter (PROBAAT-II): a multicentre randomised controlled non-inferiority trial.

Authors:  Mieke L G Ten Eikelder; Katrien Oude Rengerink; Marta Jozwiak; Jan W de Leeuw; Irene M de Graaf; Mariëlle G van Pampus; Marloes Holswilder; Martijn A Oudijk; Gert-Jan van Baaren; Paula J M Pernet; Caroline Bax; Gijs A van Unnik; Gratia Martens; Martina Porath; Huib van Vliet; Robbert J P Rijnders; A Hanneke Feitsma; Frans J M E Roumen; Aren J van Loon; Hans Versendaal; Martin J N Weinans; Mallory Woiski; Erik van Beek; Brenda Hermsen; Ben Willem Mol; Kitty W M Bloemenkamp
Journal:  Lancet       Date:  2016-02-03       Impact factor: 79.321

8.  A comparison of two dosage regimens of oral misoprostol for labor induction at term.

Authors:  Ashalatha Shetty; Ruth Martin; Peter Danielian; Allan Templeton
Journal:  Acta Obstet Gynecol Scand       Date:  2002-04       Impact factor: 3.636

9.  A randomised controlled trial of intravaginal dinoprostone, intravaginal misoprostol and transcervical balloon catheter for labour induction.

Authors:  M Prager; E Eneroth-Grimfors; M Edlund; L Marions
Journal:  BJOG       Date:  2008-08-19       Impact factor: 6.531

Review 10.  Oral misoprostol for induction of labour.

Authors:  Zarko Alfirevic; Nasreen Aflaifel; Andrew Weeks
Journal:  Cochrane Database Syst Rev       Date:  2014-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.